You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 291 No. 2, January 14, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Bioterrorism
 •Alert me on articles by topic

Treatment of Sarin Exposure

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Lee1 noted that "early endotracheal intubation and ventilatory support are critical . . . " in treating severely injured patients after sarin exposure. We disagree, however, with his assertion that succinylcholine should be avoided during rapid sequence intubation in these patients.

Death from sarin exposure is generally because of hypoxia from airway obstruction, weakness of the respiratory muscles, seizures, or respiratory failure.2 In patients with severe trauma, rapid sequence intubation with succinylcholine is the standard method of airway management. As Lee stated, sarin inhibits both acetylcholinesterase ("true" cholinesterase) and butyrylcholinesterase (pseudocholinesterase). Because succinylcholine is metabolized by butyrylcholinesterase, a patient exposed to sarin who receives succinylcholine would be expected to have prolonged neuromuscular blockade. This has been reported in patients who received succinylcholine after organophosphate insecticide poisoning.3 The duration of paralysis in most cases, however, was less than 4 hours. Similar prolongation of neuromuscular blockade has been . . . [Full Text of this Article]

Peter DeBalli, MD; D. Ryan Cook, MD
Department of Anesthesiology
Duke University Medical Center
Durham, NC


RELATED ARTICLES

Treatment of Sarin Exposure
Amir Krivoy, Ido Layish, Eran Rotman, and Yoav Yehezkelli
JAMA. 2004;291(2):181.
EXTRACT | FULL TEXT  

Treatment of Sarin Exposure
Joshua G. Schier and Robert S. Hoffman
JAMA. 2004;291(2):182.
EXTRACT | FULL TEXT  

Treatment of Sarin Exposure—Reply
Ernest C. Lee
JAMA. 2004;291(2):182-183.
EXTRACT | FULL TEXT  

Clinical Manifestations of Sarin Nerve Gas Exposure
Ernest C. Lee
JAMA. 2003;290(5):659-662.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.